About Nanjing King-Friend Biochemical Pharmaceutical Company

The company is located in Nanjing, China, and is committed to building a world-class biopharmaceutical company, creating an integrated pharmaceutical internationalization platform, and becoming a bridgehead for domestic companies to enter the international market. It has a mature R&D, quality, registration, and sales team in the US, and has grown into one of the most important high-end injectable suppliers in the US at the rate of more than a dozen ANDA approvals every year. The company is a pharmaceutical enterprise integrating R&D, production and sales of pharmaceuticals. It actively lays out the fields of chemicals and biopharmaceuticals, and has established a rich product pipeline covering cardiovascular, neurological, anesthetic, antitumor preparations, surgical aids, and other high-value-added sterile injections. The company's main products include enoxaparin sodium injections, daxaparin sodium injections, and nadroparin calcium injections, which are low molecular weight heparin preparations, fluvizin injections, carboplatin injections, azacitidine injections, busulfan injections, bendamustine hydrochloride for injections, melphalan hydrochloride for injections, fluorouracil injections, etc. Company honors: Jiangsu Certified Enterprise Technology Center, Jiangsu Open Economy Advanced Enterprise, Nanjing Municipal Key Agricultural Commercialization Leading Enterprise, etc.